AMN Healthcare Q2 FY26 GAAP EPS turns to profit at $0.53; revenue rises 2% to $673 million vs Q2 FY25
AMN•Segment performance
Nurse and Allied Solutions revenue rose 11% to $422 million, while Technology and Workforce Solutions fell 15% to $87 million.
Third-quarter outlook
For Q3 2026, AMN forecast revenue of $640 million-$655 million, with adjusted EBITDA margin seen at 6.5%-7%.
Q2 results improve on higher revenue and profit
AMN Healthcare posted Q2 2026 revenue of $673.2 million, up 2% year over year, as GAAP net income swung to $21.2 million.
GAAP diluted EPS was $0.53; adjusted diluted EPS rose to $0.77 from $0.30 a year earlier, while adjusted EBITDA increased 26% to $73.4 million.
Gross margin widened 0.8 percentage points to 30.6%, helped by reserve releases and billing true-ups tied to earlier labor disruption events.
